Posts
The patient registry software market is expected to witness a
significant growth over the next five years. The reason for this is the
ever-expanding focus on healthcare delivery, particularly in the non-clinical
fields of patient care, education, prevention and public health. Patient safety
is being continuously refined with the advent of new devices and applications
in the clinical laboratories. Certain drivers are also behind the patient
registry growth. These include adoption of EHR, creation of patient registries
to track patient records, and greater use of electronic medical records (EMR)
for post-marketing management.
Market Dynamics
Increasing prevalence of cancer and other chronic disorders is
expected to propel growth of the global patient
registry software market. For instance, according to the study, “Global and
regional diabetes prevalence estimates for 2019 and projections for 2030 and
2045: Results from the International Diabetes Federation Diabetes Atlas, 9th
edition”, published in the journal Diabetes Research and Clinical Practice, in
September 2019, 463 million people are expected to suffer from diabetes in 2019
worldwide and the number is expected to reach 578 million by 2030 and 700
million by 2045.
Emergence of pandemic diseases is expected to offer lucrative growth
opportunities for players in the patient registry software market. For
instance, globally, as of 5:05pm CET, 17 December 2020, there have been
72,851,747 confirmed cases of COVID-19, including 1,643,339 deaths, reported to
the World Health Organization.
Moreover, increasing number of clinical trials is also expected to
aid in growth of the market. For instance, according to the U.S. FDA’s 2019
Drugs Trials Snapshot, 2019 witnessed 48 novel drug approvals, either under New
Drug Applications or as new therapeutic biologics under Biologics License
Applications, with a total of 46,391 patients participating in clinical trials
to support the safety and efficacy of these products.
Moreover, lack of healthcare IT professionals, especially in
emerging economies is also expected to hinder growth of the market.
Competitive Analysis
Major players operating in the patient registry software market
include, Global Vision Technologies, Inc., IQVIA, Dacima Software Inc.,
PatientCrossroads, Mckesson Corporation, Liaison Technologies, and Imagetrend,
Inc. and Evado eClinical Solutions.
Major players operating in the patient registry software market
are focused on adopting collaboration strategies to enhance their market share.
For instance, in December 2020, IQVIA collaborated with Servier, an independent
global pharmaceutical company, to reinvent their R&D clinical development
processes and support their long-term R&D success.
No comments:
Post a Comment